Short answer
When designing healthcare access models, prioritize affordability and equitable distribution of costs, ensuring that essential services and products remain accessible to all user segments.
- Field
- User-Centred Design
- Source
- London School of Economics and Political Science Research Online (London School of Economics and Political Science) (2017)
- Method
- Policy analysis and literature review
- Evidence
- Moderate effect
Increasing co-payment levels within a publicly funded health system can disproportionately burden users, especially for essential items like pharmaceuticals. This user-centred design research insight is drawn from a 2017 study published in London School of Economics and Political Science Research Online (London School of Economics and Political Science). Using Policy analysis and literature review, researchers explored how this design variable affects real-world outcomes. The key design takeaway: When designing healthcare access models, prioritize affordability and equitable distribution of costs, ensuring that essential services and products remain accessible to all user segments.
Co-payments in National Health Services Increase User Cost-Sharing, Particularly for Pharmaceuticals
Increasing co-payment levels within a publicly funded health system can disproportionately burden users, especially for essential items like pharmaceuticals.
London School of Economics and Political Science Research Online (London School of Economics and Political Science) · 2017
Key Findings
- 01Portugal's NHS is primarily tax-funded, providing universal access.
- 02Co-payments have progressively increased, with the highest burden on pharmaceutical products.
- 03A significant portion of the population utilizes supplementary private health insurance.
- 04Both public and private providers are involved in healthcare delivery.
Application
Design takeaway
When designing healthcare access models, prioritize affordability and equitable distribution of costs, ensuring that essential services and products remain accessible to all user segments.
How to apply
When developing healthcare policies or designing patient support programs, analyze the full spectrum of user costs, including direct payments, co-pays, and out-of-pocket expenses, to ensure affordability.
Project actions
- 01Consider how financial barriers might affect user engagement with a designed health service.
- 02Investigate the cost structures associated with different healthcare options when evaluating user choices.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Provides a real-world case study of health system financing and user impact.
- +Highlights the interplay between public policy and user behaviour.
Limitations
The specific economic context of Portugal might differ from your project's target market. The study doesn't detail the impact on specific user demographics.
Reliability & validity
The findings are based on a review of existing literature and policy, suggesting moderate reliability. Validity depends on the quality and scope of the original sources reviewed.
Think critically
How might the increasing reliance on private insurance, as observed in Portugal, lead to a two-tiered healthcare system and exacerbate existing health inequalities?
Design Principles
"Equitable access to essential services should be maintained through carefully designed cost-sharing mechanisms that do not disproportionately burden vulnerable user groups."
Understanding the financial barriers users face is crucial for designing equitable and accessible healthcare systems. This insight highlights how policy decisions on cost-sharing directly impact user experience and access to care, influencing their choices and potentially leading to disparities.
What This Means for Your Design
Even in systems where healthcare is 'free' at the point of use, hidden costs like co-payments can make it hard for people to get the medicines or treatments they need, especially if they have to pay more for drugs.
How to use in your project
- 1.Use this insight to justify the importance of considering affordability and cost-sharing in your design project's user research and evaluation phases.
Add to My Project
Quick Cite
Paragraph starter
The Portuguese health system review highlights how increasing co-payments, particularly for pharmaceuticals, can create significant financial barriers for users, impacting their access to essential healthcare. This underscores the importance of considering the full economic landscape users navigate when designing health-related services or policies to ensure equitable access.
Source
London School of Economics and Political Science Research Online (London School of Economics and Political Science)
Portugal:: Health System review, 2017
journal · 2017
View sourceQuestions About This Research
- What does the research say about co-payments in national health services increase user cost-sharing, particularly for pharmaceuticals?
- When designing healthcare access models, prioritize affordability and equitable distribution of costs, ensuring that essential services and products remain accessible to all user segments. Evidence: London School of Economics and Political Science Research Online (London School of Economics and Political Science) (2017).
- Why does "Co-payments in National Health Services Increase User Cost-Sharing, Particularly for Pharmaceuticals" matter for design?
- Understanding the financial barriers users face is crucial for designing equitable and accessible healthcare systems. This insight highlights how policy decisions on cost-sharing directly impact user experience and access to care, influencing their choices and potentially leading to disparities.
- How can designers apply this research?
- When designing healthcare access models, prioritize affordability and equitable distribution of costs, ensuring that essential services and products remain accessible to all user segments.
- What were the main findings?
- Portugal's NHS is primarily tax-funded, providing universal access.. Co-payments have progressively increased, with the highest burden on pharmaceutical products.. A significant portion of the population utilizes supplementary private health insurance.. Both public and private providers are involved in healthcare delivery.
- What research method was used?
- Policy analysis and literature review.
- How strong is the evidence?
- Evidence strength is rated Moderate effect, based on a 2017 journal from London School of Economics and Political Science Research Online (London School of Economics and Political Science).
- What should I do differently in my next project?
- When developing healthcare policies or designing patient support programs, analyze the full spectrum of user costs, including direct payments, co-pays, and out-of-pocket expenses, to ensure affordability.
- What are the limitations?
- The study focuses on Portugal and may not be directly generalizable to all healthcare systems. The specific impact on different socio-economic groups within Portugal is not detailed.